CRIS

Curis, Inc. (Ticker: CRIS), based in Lexington, Massachusetts, is a biotechnology company dedicated to developing innovative targeted therapies for oncology, addressing critical unmet medical needs. Utilizing proprietary platforms, Curis has established a robust pipeline of promising drug candidates aimed at improving treatment outcomes for various types of cancer. With a strong commitment to research and development, Curis is well-positioned to make significant contributions to the future of cancer care, striving to tackle the intricacies of cancer treatment and enhance the quality of life for patients.